ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism
Linchong Sun(Guangdong Academy of Medical Sciences), Ping Gao(University of Science and Technology of China), Pinggen Zhang(University of Science and Technology of China), Xuemei Gu(Shanghai Eighth People Hospital), Weidong Jia(Anhui Provincial Hospital), Wenhao Ma(Beijing Technology and Business University), Caixia Suo(Guangzhou First People's Hospital), Haoran Wei(University of Science and Technology of China), Shiqiao Qiu(South China University of Technology), Tong Zhang(Pacific Northwest National Laboratory), Rui Chen(Jiangnan University), Huafeng Zhang(University of Science and Technology of China), Shengqi Shen(University of Science and Technology of China), Jie Cao(Second Affiliated Hospital of Guangzhou Medical University), Ronghui Yan(Suzhou University of Science and Technology)
Cited by 71
Related Papers
Metabolic reprogramming and epigenetic modifications on the path to cancer
|Protein & Cell|2021|737
Emerging contaminants: A One Health perspective
|The Innovation|2024|497
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions
|Cell Research|2015|316
Harnessing copper-palladium alloy tetrapod nanoparticle-induced pro-survival autophagy for optimized photothermal therapy of drug-resistant cancer
|Nature Communications|2018|209
ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1
|Nature Cancer|2021|203